Aims/hypothesis: Inflammation induces beta cell dysfunction and demise but underlying molecular mechanisms remain unclear. The apolipoprotein L (APOL) family of genes has been associated with innate immunity and apoptosis in non-pancreatic cell types, but also with metabolic syndrome and type 2 diabetes mellitus. Here, we hypothesised that APOL genes play a role in inflammation-induced beta cell damage.
Methods: We used single-cell transcriptomics datasets of primary human pancreatic islet cells to study the expression of APOL genes upon specific stress conditions. Validation of the findings was carried out in EndoC-βH1 cells and primary human islets. Finally, we performed loss- and gain-of-function experiments to investigate the role of APOL genes in beta cells.
Results: APOL genes are expressed in primary human beta cells and APOL1, 2 and 6 are strongly upregulated upon inflammation via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway. APOL1 overexpression increases endoplasmic reticulum stress while APOL1 knockdown prevents cytokine-induced beta cell death and interferon-associated response. Furthermore, we found that APOL genes are upregulated in beta cells from donors with type 2 diabetes compared with donors without diabetes mellitus.
Conclusions/interpretation: APOLs are novel regulators of islet inflammation and may contribute to beta cell damage during the development of diabetes.
Data Availability: scRNAseq data generated by our laboratory and used in this study are available in the Gene Expression Omnibus (GEO; www.ncbi.nlm.nih.gov/geo/ ), accession number GSE218316.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10709252 | PMC |
| http://dx.doi.org/10.1007/s00125-023-06033-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Apolipoprotein-L Functions in Membrane Remodeling.
Cells
December 2024
Laboratory of Molecular Parasitology, Institut de Biologie et de Médecine Moléculaires (IBMM), Université Libre de Bruxelles, 6041 Gosselies, Belgium.
The mammalian Apolipoprotein-L families (APOLs) contain several isoforms of membrane-interacting proteins, some of which are involved in the control of membrane dynamics (traffic, fission and fusion). Specifically, human APOL1 and APOL3 appear to control membrane remodeling linked to pathogen infection. Through its association with Non-Muscular Myosin-2A (NM2A), APOL1 controls Golgi-derived trafficking of vesicles carrying the lipid scramblase Autophagy-9A (ATG9A).
View Article and Find Full Text PDFProtein-truncating variant in APOL3 increases chronic kidney disease risk in epistasis with APOL1 risk alleles.
JCI Insight
October 2024
Department of Genetics.
BACKGROUNDTwo coding alleles within the APOL1 gene, G1 and G2, found almost exclusively in individuals genetically similar to West African populations, contribute substantially to the pathogenesis of chronic kidney disease (CKD). The APOL gene cluster on chromosome 22 contains a total of 6 APOL genes that have arisen as a result of gene duplication.METHODSUsing a genome-first approach in the Penn Medicine BioBank, we identified 62 protein-altering variants in the 6 APOL genes with a minor allele frequency of >0.
View Article and Find Full Text PDFGenetic spectrum of sarcoglycanopathies in a cohort of Russian patients.
Gene
November 2024
Research Centre for Medical Genetics, Moscow, Russia. Electronic address:
Article Synopsis
- Sarcoglycanopathies are a group of limb-girdle muscular dystrophies (LGMD R3-R6) caused by mutations in the SGCA, SGCB, SGCG, and SGCD genes, with low global prevalence.
- A study analyzed clinical and genetic data from 49 Russian patients, revealing that 71.4% had SGCA gene variants, while SGCB and SGCG had variants in 12.2% each, and SGCD in 4.1%.
- The most common mutations were c.229C>T and c.271G>A in SGCA, and the overall incidence of sarcoglycanopathies in Russia was estimated at 1 in 4,115
Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy.
Kidney Int
April 2024
Department of Clinical Medicine, University of Bergen, Bergen, Norway. Electronic address:
Article Synopsis
- Some patients with benign IgA nephropathy (IgAN) can unexpectedly progress, prompting researchers to study gene expression differences to predict outcomes.
- They analyzed kidney biopsies from patients, identifying specific genes that could distinguish between progressors and non-progressors, achieving 88% accuracy in predictions made decades before clinical symptoms appeared.
- The study also uncovered potential drug targets related to IgAN treatment, suggesting that glomerular mRNA sequencing at diagnosis could help identify patients at risk for disease progression.
Apolipoprotein L genes are novel mediators of inflammation in beta cells.
Diabetologia
January 2024
Department of Internal Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Aims/hypothesis: Inflammation induces beta cell dysfunction and demise but underlying molecular mechanisms remain unclear. The apolipoprotein L (APOL) family of genes has been associated with innate immunity and apoptosis in non-pancreatic cell types, but also with metabolic syndrome and type 2 diabetes mellitus. Here, we hypothesised that APOL genes play a role in inflammation-induced beta cell damage.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!